The global demand for Escitalopram Oxalate Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Escitalopram Oxalate refers to an antidepressant that belongs to a group of selective serotonin reuptake inhibitors (SSRI)s. It is also available as both a generic drug and brand-name drugs. It works by increasing serotonin levels, a chemical messenger in the brain that maintains mental balance. It comes in tablet and liquid form in the market. Escitalopram oxalate tablets are consumed to treat depression, panic disorder, and generalized anxiety disorder with or without agoraphobia. The medication relieves symptoms of anxiety, panic attacks, and obsessive-compulsive disorders. It decreases nervousness and improves sleep, mood, appetite, and energy level in an individual.
The rising prevalence of depression and anxiety disorder cases worldwide is the primary factor driving the escitalopram oxalate tablet market over the forecast time frame. The growing geriatric population with higher mental illness rates contributes to the escitalopram oxalate tablet market growth. As reported by the National Center for Health Statistics, in 2017, the percentage of adults over 60 taking antidepressants was 19.1%. As per W.H.O, in 2018, the number of people aged 80 or older was around 125 million. Moreover, changing lifestyles and increasing consumer awareness and rising demand for antidepressants due to fewer serious side effects lead to more need for the escitalopram oxalate tablet in the coming years.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of escitalopram oxalate.
The entire escitalopram oxalate market has been sub-categorized into type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Treat Depression
- Treat Obsessive-Compulsive Disorder
- Treat Anxiety
This section covers regional segmentation which accentuates on current and future demand for escitalopram oxalate market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Escitalopram Oxalate Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the escitalopram oxalate market include Xian.-Janssen, JEWIM Pharma, Ke Lun, Dr Reddy, Huahai Pharmaceutical, Nishchem International Pvt. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.